Skip to main content
SpringerLink
Log in
Book cover

Intensive Care Medicine pp 828–844Cite as

Life-threatening Neurological Complications in Patients with Malignancies

  • Conference paper

  • 1342 Accesses

Abstract

A growing number of patients with malignancies experience infectious and toxic complications related to their disease or to its treatment. The population of patients likely to require medical attention for malignant disease is expanding for three reasons: 1) The incidence of cancer is rising [1, 2], survival of patients with malignancies is improving as a result of new treatments and management strategies [2], and 3) life expectancy has increased in older individuals, patients infected with human immunodeficiency virus (HIV), and patients treated with anticancer medications or immunosuppressants [3, 4].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581–592

    Article  CAS  PubMed  Google Scholar 

  2. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360: 1131–1135

    Article  PubMed  Google Scholar 

  3. Patel P, Hanson DL, Sullivan PS, et al (2008) Incidence of types of cancer among HIVinfected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 148: 728–736

    PubMed  Google Scholar 

  4. Yabroff KR, Lamont EB, Mariotto A, et al (2008) Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 100: 630–641

    Article  PubMed  Google Scholar 

  5. Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32: 808–822

    Article  PubMed  Google Scholar 

  6. Azoulay E, Thiery G, Chevret S, et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83: 360–370

    Article  Google Scholar 

  7. Larche J, Azoulay E, Fieux F, et al (2003) Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29: 1688–1695

    Article  PubMed  Google Scholar 

  8. Pene F, Percheron S, Lemiale V, et al (2008) Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 36: 690–696

    Article  PubMed  Google Scholar 

  9. Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay E (2007) Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 33: 765–772

    Article  PubMed  Google Scholar 

  10. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24: 4003–4010

    Article  PubMed  Google Scholar 

  11. Darmon M, Ciroldi M, Thiery G, Schlemmer B, Azoulay E (2006) Clinical review: specific aspects of acute renal failure in cancer patients. Crit Care 10: 211

    Article  PubMed  Google Scholar 

  12. Plotkin SR, Wen PY (2003) Neurologic complications of cancer therapy. Neurol Clin 21: 279–318

    Article  PubMed  Google Scholar 

  13. Recht L, Mrugala M (2003) Neurologic complications of hematologic neoplasms. Neurol Clin 21: 87–105

    Article  PubMed  Google Scholar 

  14. Sul JK, Deangelis LM (2006) Neurologic complications of cancer chemotherapy. Semin Oncol 33: 324–332

    Article  CAS  PubMed  Google Scholar 

  15. Wen PY, Schiff D (2003) Neurologic complications of solid tumors. Neurol Clin 21: 107–140

    Article  PubMed  Google Scholar 

  16. Denier C, Bourhis JH, Lacroix C, et al (2006) Spectrum and prognosis of neurologic complications after hematopoietic transplantation. Neurology 67: 1990–1997

    Article  CAS  PubMed  Google Scholar 

  17. Louis DN, Ohgaki H, Wiestler OD, et al (2007) The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol (Berl) 114: 97–109

    Article  Google Scholar 

  18. De Angelis LM (2001) Brain tumors. N Engl J Med 344: 114–123

    Article  Google Scholar 

  19. Morgenstern LB, Frankowski RF (1999) Brain tumor masquerading as stroke. J Neurooncol 44: 47–52

    Article  CAS  PubMed  Google Scholar 

  20. Metcalfe SE, Grant R (2001) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev CD002034

    Google Scholar 

  21. Bataille B, Delwail V, Menet E, et al (2000) Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92: 261–266

    Article  CAS  PubMed  Google Scholar 

  22. Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21: 1–23

    Article  PubMed  Google Scholar 

  23. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19: 579–592

    CAS  PubMed  Google Scholar 

  24. Demir H, Berk F, Raderer M, et al (2004) The role of nuclear medicine in the diagnosis of cancer of unknown origin. Q J Nucl Med Mol Imaging 48: 164–173

    CAS  PubMed  Google Scholar 

  25. Lassen U, Daugaard G, Eigtved A, Damgaard K, Friberg L (1999) 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT). Eur J Cancer 35: 1076–1082

    Article  CAS  PubMed  Google Scholar 

  26. Andrews DW (2008) Current neurosurgical management of brain metastases. Semin Oncol 35: 100–107

    Article  PubMed  Google Scholar 

  27. Byrne TN, Borges LF, Loeffler JS (2006) Metastatic epidural spinal cord compression: update on management. Semin Oncol 33: 307–311

    Article  PubMed  Google Scholar 

  28. Pavlidis N (2004) The diagnostic and therapeutic management of leptomeningeal carcinomatosis. Ann Oncol 15 (Suppl 4): iv285–291

    Google Scholar 

  29. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23: 3605–3613

    Article  PubMed  Google Scholar 

  30. Gleissner B, Chamberlain MC (2006) Neoplastic meningitis. Lancet Neurol 5: 443–452

    Article  PubMed  Google Scholar 

  31. Nieuwenhuizen L, Biesma DH (2008) Central nervous system myelomatosis: review of the literature. Eur J Haematol 80: 1–9

    Article  PubMed  Google Scholar 

  32. Jaeckle KA (2006) Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment. Semin Oncol 33: 312–323

    Article  PubMed  Google Scholar 

  33. Ramchandren S, Dalmau J (2005) Metastases to the peripheral nervous system. J Neurooncol 75: 101–110

    Article  PubMed  Google Scholar 

  34. Antoine JC, Camdessanche JP (2007) [Paraneoplastic neurological syndromes]. Presse Med 36: 1418–1426

    Article  PubMed  Google Scholar 

  35. Pruitt AA (2004) Central nervous system infections in cancer patients. Semin Neurol 24: 435–452

    Article  PubMed  Google Scholar 

  36. Safdieh JE, Mead PA, Sepkowitz KA, Kiehn TE, Abrey LE (2008) Bacterial and fungal meningitis in patients with cancer. Neurology 70: 943–947

    Article  CAS  PubMed  Google Scholar 

  37. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351: 1849–1859

    Article  PubMed  Google Scholar 

  38. Klastersky J, Aoun M (2004) Opportunistic infections in patients with cancer. Ann Oncol 15 (Suppl 4): iv329–iv335

    PubMed  Google Scholar 

  39. Dougan C, Ormerod I (2004) A neurologist’s approach to the immunosuppressed patient. J Neurol Neurosurg Psychiatry 75 (Suppl 1): i43–49

    Article  Google Scholar 

  40. Segal BH, Freifeld AG, Baden LR, et al (2008) Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 6: 122–174

    PubMed  Google Scholar 

  41. Rogers LR (2003) Cerebrovascular complications in cancer patients. Neurol Clin 21: 167–192

    Article  PubMed  Google Scholar 

  42. Graus F, Rogers LR, Posner JB (1985) Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 64: 16–35

    CAS  Google Scholar 

  43. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM (2004) Stroke in patients with cancer: incidence and etiology. Neurology 62: 2025–2030

    CAS  PubMed  Google Scholar 

  44. Coplin WM, Cochran MS, Levine SR, Crawford SW (2001) Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain 124: 1043–1051

    Article  CAS  PubMed  Google Scholar 

  45. Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543–1554

    Article  CAS  PubMed  Google Scholar 

  46. Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327–340

    Article  PubMed  Google Scholar 

  47. Darnell RB, Posner JB (2006) Paraneoplastic syndromes affecting the nervous system. Semin Oncol 33: 270–298

    Article  PubMed  Google Scholar 

  48. Honnorat J, Antoine JC (2007) Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2: 22

    Article  PubMed  Google Scholar 

  49. de Beukelaar JW, Sillevis Smitt PA (2006) Managing paraneoplastic neurological disorders. Oncologist 11: 292–305

    Article  PubMed  Google Scholar 

  50. Vedeler CA, Antoine JC, Giometto B, et al (2006) Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13: 682–690

    Article  CAS  PubMed  Google Scholar 

  51. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63: 1549–1563

    Article  CAS  PubMed  Google Scholar 

  52. Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69: 894–897

    Article  CAS  PubMed  Google Scholar 

  53. Hinchey J, Chaves C, Appignani B, et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494–500

    Article  CAS  PubMed  Google Scholar 

  54. Lamy C, Oppenheim C, Meder JF, Mas JL (2004) Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14: 89–96

    CAS  PubMed  Google Scholar 

  55. Legriel S, Bruneel F, Spreux-Varoquaux O, et al (2008) Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care 9: 247–252

    Article  PubMed  Google Scholar 

  56. Laack NN, Brown PD (2004) Cognitive sequelae of brain radiation in adults. Semin Oncol 31: 702–713

    Article  PubMed  Google Scholar 

  57. Cross NE, Glantz MJ (2003) Neurologic complications of radiation therapy. Neurol Clin 21: 249–277

    Article  PubMed  Google Scholar 

  58. Soffietti R, Cornu P, Delattre JY, et al (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13: 674–681

    Article  CAS  PubMed  Google Scholar 

  59. Delaney A, Fleetwood-Walker SM, Colvin LA, Fallon M (2008) Translational medicine: cancer pain mechanisms and management. Br J Anaesth 101: 87–94

    Article  CAS  PubMed  Google Scholar 

  60. Miovic M, Block S (2007) Psychiatric disorders in advanced cancer. Cancer 110: 1665–1676

    Article  PubMed  Google Scholar 

  61. Spinazze S, Schrijvers D (2006) Metabolic emergencies. Crit Rev Oncol Hematol 58: 79–89

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, Hôpital André Mignot, 177 rue de Versaille, 78150, Le Chesnay, France

    S. Legriel

  2. Department of Intensive Care, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France

    E. Azoulay

Authors
  1. S. Legriel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Azoulay
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Universitée libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Legriel, S., Azoulay, E. (2009). Life-threatening Neurological Complications in Patients with Malignancies. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92278-2_76

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-92278-2_76

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-92277-5

  • Online ISBN: 978-0-387-92278-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation